Clinicians & Researchers

You are here

PETAL Network Bibliography

Export 55 results:

RTF
Tagged

Author Title Type [ Year

]

2016

Gong MNg, B Thompson T. 2016. Acute respiratory distress syndrome: shifting the emphasis from treatment to prevention. Current opinion in critical care. 22(1):21-37.

Huang DT, Angus DC, Moss M, Thompson BT, Ferguson ND, Ginde A, Gong MN, Gundel S, Hayden DL, Hite RD et al.. 2016. Design and Rationale of the Reevaluation of Systemic Early Neuromuscular Blockade (ROSE) Trial for Acute Respiratory Distress Syndrome.. Annals of the American Thoracic Society.

RTF
Tagged

Benthin C, Pannu S, Khan A, Gong M. 2016. The Nature and Variability of Automated Practice Alerts Derived from Electronic Health Records in a U.S. Nationwide Critical Care Research Network.. Ann Am Thorac Soc. 13(10):1784-1788.

Brown SM, Grissom CK, Moss M, Rice TW, Schoenfeld D, Hou P, B Thompson T, Brower RG. 2016. Non-linear imputation of PaO2/FIO2 from SpO2/FIO2 among patients with Acute Respiratory Distress Syndrome.. Chest.

Sjoding MW, Schoenfeld DA, Brown SM, Hough CL, Yealy DM, Moss M, Angus DC, Iwashyna TJ, Network. NHLBIPrevention. 2016. Power Calculations to Select Instruments for Clinical Trial Secondary Endpoints: A Case Study of Instrument Selection for Post-Traumatic Stress Symptoms in Subjects with ARDS.. Annals of the American Thoracic Society.

RTF
Tagged

Beitler JR, Malhorta A, Thompson BT. 2016. Ventilator-induced Lung Injury.

2017

B Thompson T, Chamber RC, Liu KD. 2017. Acute Respiratory Distress Syndrome. The New England Journal of Medicine. 377(6):562-572.

Thompson BT. 2017. Acute respiratory distress syndrome in another 50 years: historical footnote or persistent malady?

Huang DT, Angus DC, Moss M, Thompson BT, Ferguson ND, Ginde A, Gong MN, Gundel S, Hayden DL, Hite RD et al.. 2017. Design and Rationale of the Reevaluation of Systemic Early Neuromuscular Blockade Trial for Acute Respiratory Distress Syndrome.

Thompson BT. 2017. Greater Treatment Effect With Lower Disease Severity: VASST Insights.

Walkey AJ, Del Sorbo L, Hodgson CL, Adhikari NKJ, Wunsch H, Meade MO, Uleryk E, Hess D, Talmor DS, Thompson BT et al.. 2017. Higher PEEP versus Lower PEEP Strategies for Patients with Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis.

Walkey AJ, Goligher EC, Del Sorbo L, Hodgson CL, Adhikari NKJ, Wunsch H, Meade MO, Uleryk E, Hess D, Talmor DS et al.. 2017. Low Tidal Volume versus Non-Volume-Limited Strategies for Patients with Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis.

Brown SM, Duggal A, Tidswell M, Khan A, Exline M, Park PK, Schoenfeld DS, Liu M, Grissom CK, Moss M et al.. 2017. Nonlinear Imputation of PaO2/FIO2 From SpO2/FIO2 Among Mechanically Ventilated Patients in the ICU: A Prospective, Observational Study.. Critical Care Medicine. 45(8):1317-1324.

Fan E, Del Sorbo L, Goligher EC, Hodgson CL, Munshi L, Walkey AJ, Adhikari NKJ, Amato M, Branson R, Brower RG et al.. 2017. An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: Mechanical Ventilation in Adult Patients with Acute Respiratory Distress Syndrome.

Aggarwal NR, Brower RG, Hager DN, Thompson BT, Netzer G, Shanholtz C, Lagakos A, Checkley W, Investigators NInstitutes. 2017. Oxygen Exposure Resulting in Arterial Oxygen Tensions Above the Protocol Goal Was Associated with Worse Clinical Outcomes in Acute Respiratory Distress Syndrome.

Jolley SElizabeth, Moss M, Needham DM, Caldwell E, Morris PE, Miller RR, Ringwood N, Anders M, Koo KK, Gundel SE et al.. 2017. Point Prevalence Study of Mobilization Practices for Acute Respiratory Failure Patients in the United States.. Crit Care Med. 45(2):205-215.

Sjoding MW, Schoenfeld DA, Brown SM, Hough CL, Yealy DM, Moss M, Angus DC, Iwashyna TJ. 2017. Power Calculations to Select Instruments for Clinical Trial Secondary Endpoints. A Case Study of Instrument Selection for Post-Traumatic Stress Symptoms in Subjects with Acute Respiratory Distress Syndrome.. Ann Am Thorac Soc. 14(1):110-117.

Jolley SE, Hough CL, Clermont G, Hayden D, Hou S, Schoenfeld D, Smith NL, Thompson BT, Bernard GR, Angus DC et al.. 2017. Relationship between Race and the Effect of Fluids on Long-term Mortality after Acute Respiratory Distress Syndrome. Secondary Analysis of the National Heart, Lung, and Blood Institute Fluid and Catheter Treatment Trial..

Chiumello D, Brochard L, Marini JJ, Slutsky AS, Mancebo J, Ranieri VM, Thompson BT, Papazian L, Schultz MJ, Amato M et al.. 2017. Respiratory support in patients with acute respiratory distress syndrome: an expert opinion..

Meade MO, Young D, Hanna S, Zhou Q, Bachman TE, Bollen C, Slutski AS, Lamb SE, Adhikari NKJ, Mentzelopoulou SD et al.. 2017. Severity of Hypoxemia and Effect of High-Frequency Oscillatory Ventilation in Acute Respiratory Distress Syndrome.

2018

Self WH, Semler MW, Bellomo R, Brown SM, deBoisblanc BP, Exline MC, Ginde AA, Grissom CK, Janz DR, Jones AE et al.. 2018. Liberal Versus Restrictive Intravenous Fluid Therapy for Early Septic Shock: Rationale for a Randomized Trial.. Ann Emerg Med. 72(4):457-466.

2019

Ginde AA, Brower RG, Caterino JM, Finck L, Banner-Goodspeed VM, Grissom CK, Hayden D, Hough CL, Hyzy RC, Khan A et al.. 2019. Early High-Dose Vitamin D for Critically Ill, Vitamin D-Deficient Patients.. N Engl J Med. 381(26):2529-2540.

Moss M, Huang DT, Brower RG, Ferguson ND, Ginde AA, Gong MN, Grissom CK, Gundel S, Hayden D, R Hite D et al.. 2019. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.. N Engl J Med. 380(21):1997-2008.

Moss M, Ulysse CA, Angus DC. 2019. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome. Reply.. N Engl J Med. 381(8):787-788.

Lanspa MJ, Gong MNg, Schoenfeld DA, Lee KTiffany, Grissom CK, Hou PC, Serpa-Neto A, Brown SM, Iwashyna TJ, Yealy DM et al.. 2019. Prospective Assessment of the Feasibility of a Trial of Low-Tidal Volume Ventilation for Patients with Acute Respiratory Failure.. Ann Am Thorac Soc. 16(3):356-362.

2020

Self WH, Semler MW, Leither LM, Casey JD, Angus DC, Brower RG, Chang SY, Collins SP, Eppensteiner JC, Filbin MR et al.. 2020. Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial . JAMA.

Hauschildt KE, Seigworth C, Kamphuis LA, Hough CL, Moss M, McPeake JM, Iwashyna TJ. 2020. Financial Toxicity After Acute Respiratory Distress Syndrome: A National Qualitative Cohort Study.. Crit Care Med. 48(8):1103-1110.

Ginde AA, Talmor D. 2020. High-Dose Vitamin D3 for Critically Ill Vitamin D-Deficient Patients. Reply.. N Engl J Med. 382(17):1670-1671.

Baron RM, Christman JW, Liu KD, Matthay MA, Self WH, McVerry BJ, Hite RDuncan, Paine R, Wurfel MM, Shapiro NI et al.. 2020. Monitoring Research Blood Sampling in Critically Ill Patients: Avoiding Iatrogenic Anemia.. Am J Respir Crit Care Med. 202(6):885-887.

Casey JD, Johnson NJ, Semler MW, Collins SP, Aggarwal NR, Brower RG, Chang SY, Eppensteiner J, Filbin M, Gibbs KW et al.. 2020. Rationale and Design of ORCHID: A Randomized Placebo-controlled Clinical Trial of Hydroxychloroquine for Adults Hospitalized with COVID-19.. Ann Am Thorac Soc. 17(9):1144-1153.

2021

Peltan ID, Caldwell E, Admon AJ, Attia EF, Gundel SJ, Mathews KS, Nagrebetsky A, Sahetya SK, Ulysse C, Brown SM et al.. 2021. Characteristics and Outcomes of US Patients Hospitalized With COVID-19. American Journal of Critical Care.

Iwashyna TJ, Kamphuis LA, Gundel SJ, Hope AA, Jolley S, Admon AJ, Caldwell E, Monahan ML, Hauschildt K, B Thompson T et al.. 2021. Continuing Cardiopulmonary Symptoms, Disability, and Financial Toxicity 1 Month After Hospitalization for Third-Wave COVID-19: Early Results From a US Nationwide Cohort.. J Hosp Med.

Han JH, Ginde AA, Brown SM, Baughman A, Collar EM, E Ely W, Gong MN, Hope AA, Hou PC, Hough CL et al.. 2021. Effect of Early High-Dose Vitamin D3 Repletion on Cognitive Outcomes in Critically Ill Adults.. Chest. 160(3):909-918.

Lundgren JD, Grund B, Barkauskas CE, Holland TL, Gottlieb RL, Sandkovsky U, Brown SM, Knowlton KU, Self WH, D Files C et al.. 2021. A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.. N Engl J Med. 384(10):905-914.

Carlton EF, Ice E, Barbaro RP, Kampuis L, Moss M, Angus DC, Banner-Goodspeed VM, Ginde AA, Gong MN, Grissom CK et al.. 2021. Recall of clinical trial participation and attrition rates in survivors of acute respiratory distress syndrome.. J Crit Care. 64:160-164.

Goligher EC, Bradbury CA, McVerry BJ, Lawler PR, Berger JS, Gong MN, Carrier M, Reynolds HR, Kumar A, Turgeon AF et al.. 2021. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.. N Engl J Med. 385(9):777-789.

Lawler PR, Goligher EC, Berger JS, Neal MD, McVerry BJ, Nicolau JC, Gong MN, Carrier M, Rosenson RS, Reynolds HR et al.. 2021. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.. N Engl J Med. 385(9):790-802.

Mathews KS, Seitz KP, Vranas KC, Duggal A, Valley TS, Zhao B, Gundel S, Harhay MO, Chang SY, Hough CL. 2021. Variation in Initial U.S. Hospital Responses to the Coronavirus Disease 2019 Pandemic . Critical Care Medicine.

2022

Rogers AJ, Wentworth D, Phillips A, Shaw-Saliba K, Dewar RL, Aggarwal NR, Babiker AG, Dharan NJ, Davey VJ, Higgs ES et al.. 2022. The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19.. Ann Intern Med. 175(10):1401-1410.

Palakshappa JA, Russell GB, Gibbs KW, Kloefkorn C, Hayden D, Moss M, Hough CL, D Files C. 2022. Association of early sedation level with patient outcomes in moderate-to-severe acute respiratory distress syndrome: Propensity-score matched analysis.. J Crit Care. 71:154118.

Peltan ID, Caldwell E, Admon AJ, Attia EF, Gundel SJ, Mathews KS, Nagrebetsky A, Sahetya SK, Ulysse C, Brown SM et al.. 2022. Characteristics and Outcomes of US Patients Hospitalized With COVID-19. Am J Crit Care. 31(2):146-157.

Berger JS, Kornblith LZ, Gong MN, Reynolds HR, Cushman M, Cheng Y, McVerry BJ, Kim KS, Lopes RD, Atassi B et al.. 2022. Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial.. JAMA. 327(3):227-236.

Barkauskas C, Mylonakis E, Poulakou G, Young BE, Vock DM, Siegel L, Engen N, Grandits G, Mosaly NR, Vekstein AM et al.. 2022. Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial.. Ann Intern Med. 175(9):1266-1274.

ACTIV-3/Therapeutics for Inpatients with COVID-19 (TICO) Study Group. 2022. Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial.. Lancet Infect Dis. 22(5):622-625.

Mayer KP, Palakshappa JA, Peltan IDaniel, Andrew JS, Gundel SJ, Ringwood NJ, Mckeehan J, Hope AA, Rogers AJ, Biehl M et al.. 2022. Functional, imaging, and respiratory evaluation (FIRE) of patients post-hospitalization for COVID-19: protocol for a pilot observational study.. Pilot Feasibility Stud. 8(1):212.

Valley TS, Schutz A, Peltan ID, Vranas KC, Mathews KS, Jolley SE, Palakshappa JA, Hough CL. 2022. Organization of Outpatient Care After COVID-19 Hospitalization.. Chest.

Peltan ID, McLean SR, Murnin E, Butler AM, Wilson EL, Samore MH, Hough CL, Dean NC, Bledsoe JR, Brown SM. 2022. Prevalence, Characteristics, and Outcomes of Emergency Department Discharge Among Patients With Sepsis.. JAMA Netw Open. 5(2):e2147882.

Monteiro ACarolina C, Vangala S, Wick KD, Delucchi KL, Siegel ER, B Thompson T, Liu KD, Sapru A, Sinha P, Matthay MA. 2022. The prognostic value of early measures of the ventilatory ratio in the ARDS ROSE trial.. Crit Care. 26(1):297.

Lane T, Sottile PD, Peterson R, Jin Y, Moss M. 2022. Significant Variability in Surrogate Informed Consent Rates in ARDS and Prevention and Early Treatment of Acute Lung Injury Network Multicenter Trials.. Chest. 161(5):1306-1309.

ACTIV-3–Therapeutics for Inpatients with COVID-19 (TICO) Study Group. 2022. Tixagevimab-cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial.. Lancet Respir Med. 10(10):972-984.

Pages